Holen Sie sich die Stockscreener-App
9.10
1.34%
0.12
Handel nachbörslich:
8.94
-0.16
-1.76%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt NEO?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$8.98
Offen:
$9
24-Stunden-Volumen:
4.14M
Relative Volume:
1.60
Marktkapitalisierung:
$1.18B
Einnahmen:
$628.25M
Nettoeinkommen (Verlust:
$-78.55M
KGV:
-14.68
EPS:
-0.62
Netto-Cashflow:
$-29.73M
1W Leistung:
+14.75%
1M Leistung:
+11.11%
6M Leistung:
+4.36%
1J Leistung:
-35.55%
1-Tages-Spanne:
$8.825
$9.17
1-Wochen-Bereich:
$7.56
$9.17
52-Wochen-Spanne:
$4.72
$19.11
Neogenomics Inc Stock (NEO) Company Profile
Firmenname
Neogenomics Inc
Sektor
Branche
Telefon
(239) 768-0600
Adresse
9490 NEOGENOMICS WAY, FORT MYERS, FL
Vergleichen Sie NEO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEO
Neogenomics Inc
|
9.10 | 1.16B | 628.25M | -78.55M | -29.73M | -0.62 |
|
TMO
Thermo Fisher Scientific Inc
|
543.32 | 198.23B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
214.99 | 150.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
631.19 | 50.71B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.64 | 39.32B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
206.63 | 34.74B | 15.70B | 1.24B | 2.01B | 6.9036 |
Neogenomics Inc Stock (NEO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-29 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2025-05-15 | Eingeleitet | Guggenheim | Neutral |
| 2025-04-30 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-01-13 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2024-12-10 | Eingeleitet | Jefferies | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-29 | Bestätigt | BTIG Research | Buy |
| 2023-08-21 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-05-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-05-09 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-02-24 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-02-01 | Hochstufung | Needham | Hold → Buy |
| 2022-08-26 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-22 | Herabstufung | Needham | Buy → Hold |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-03-29 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-03-29 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-18 | Fortgesetzt | Stephens | Overweight |
| 2021-12-16 | Eingeleitet | Cowen | Outperform |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-14 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-25 | Fortgesetzt | Needham | Buy |
| 2021-02-25 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2020-12-11 | Fortgesetzt | BTIG Research | Buy |
| 2020-10-28 | Bestätigt | Needham | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-28 | Eingeleitet | Guggenheim | Buy |
| 2020-07-29 | Bestätigt | Needham | Buy |
| 2020-06-25 | Eingeleitet | BofA/Merrill | Buy |
| 2020-04-21 | Fortgesetzt | Stephens | Overweight |
| 2020-03-02 | Fortgesetzt | Craig Hallum | Buy |
| 2020-02-28 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2020-01-23 | Herabstufung | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-30 | Bestätigt | Needham | Buy |
| 2019-05-01 | Bestätigt | Needham | Buy |
| 2019-03-29 | Bestätigt | Needham | Buy |
| 2019-01-03 | Eingeleitet | Needham | Buy |
| 2018-10-24 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2018-08-21 | Eingeleitet | Leerink Partners | Outperform |
| 2018-05-02 | Herabstufung | First Analysis Sec | Overweight → Equal-Weight |
| 2017-09-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2017-08-24 | Eingeleitet | Gabelli & Co | Buy |
| 2016-12-15 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Neogenomics Inc Aktie (NEO) Neueste Nachrichten
What catalysts could drive NeoGenomics Inc. stock higherJuly 2025 PreEarnings & Stock Portfolio Risk Control - newser.com
Is NeoGenomics Inc. (NG9) stock good for wealth creationTrade Exit Summary & Weekly High Return Forecasts - newser.com
What valuation multiples suggest for NeoGenomics Inc. stockPortfolio Value Summary & Low Drawdown Investment Ideas - newser.com
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know - The Globe and Mail
Strategies to average down on NeoGenomics Inc.2025 Earnings Surprises & Daily Entry Point Trade Alerts - newser.com
NeoGenomics (NASDAQ:NEO Shareholders Incur Further Losses as Stock Declines 7.5% This Week, Taking Five-year Losses to 79% - 富途牛牛
Opportunities in the Booming AI in Bioinformatics Market: A $26+ Billion Industry by 2029 Led by Thermo Fisher Scientific, Eurofins Scientific, Dassault Systemes, Illumina and NeoGenomics Laboratories - Yahoo Finance
NeoGenomics (NEO): Exploring Current Valuation After Recent Share Price Volatility - Yahoo Finance
Is NeoGenomics Inc a good long term investmentCurrency Fluctuation Impact & Small Capital Growth Stocks - earlytimes.in
NeoGenomics, Inc. (NASDAQ:NEO) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
United States Clinical Laboratory Services Market Poised - openPR.com
Here’s Alger Weatherbie Specialized Growth Fund’s Comment on NeoGenomics (NEO) - Yahoo
NeoGenomics (NEO) Tops Q4 Earnings Estimates - MSN
Guidance Update: How does NeoGenomics Inc perform in inflationary periods2025 Technical Patterns & Safe Capital Growth Stock Tips - خودرو بانک
Sectors Review: Can FANG reach resistance levels soonMarket Volume Summary & Weekly Watchlist of Top Performers - khodrobank.com
Big Money Moves: What is NeoGenomics Inc. s debt to equity ratioTrade Analysis Report & AI Driven Price Predictions - خودرو بانک
Market Trends: Is Centerra Gold Inc. a turnaround storyRate Cut & AI Optimized Trade Strategies - khodrobank.com
Published on: 2025-09-19 15:28:49 - خودرو بانک
NeoGenomics (NASDAQ:NEO) Stock Price Down 3.8%Here's Why - MarketBeat
NeoGenomics rallies after court win in Natera patent dispute - MSN
Options Flow: Can Fenbo Holdings Limited scale operations efficientlyEarnings Performance Report & Smart Swing Trading Techniques - khodrobank.com
Market Outlook: Can NeoGenomics Inc keep up with sector leadersJuly 2025 Momentum & Breakout Confirmation Trade Signals - خودرو بانک
Risk Hedge: Why is NeoGenomics Inc. stock going up2025 Trade Ideas & Free Community Consensus Stock Picks - خودرو بانک
FOMO Trade: What is Gain Therapeutics Incs 5 year growth outlookJuly 2025 Movers & Low Risk High Reward Trade Ideas - khodrobank.com
TD Cowen Issues Positive Forecast for NeoGenomics (NASDAQ:NEO) Stock Price - MarketBeat
Can NeoGenomics Inc keep up with sector leadersMarket Activity Recap & Real-Time Volume Spike Alerts - خودرو بانک
Aug Gainers: What is NeoGenomics Incs 5 year growth outlook2025 Performance Recap & Free Technical Pattern Based Buy Signals - khodrobank.com
NeoGenomics (NASDAQ:NEO) Stock Price Up 8.5%Here's What Happened - MarketBeat
Weekly Trades: Is NeoGenomics Inc stock undervalued right nowQuarterly Performance Summary & Real-Time Stock Entry Alerts - خودرو بانک
Analyst Calls: Does NeoGenomics Inc. have a sustainable dividendQuarterly Trade Review & Growth Oriented Trade Recommendations - خودرو بانک
Sell Signal: Can NeoGenomics Inc stock outperform in a bear marketNew Guidance & Free Technical Confirmation Trade Alerts - خودرو بانک
Sectors Review: Why is NeoGenomics Inc stock going upEarnings Risk Summary & Consistent Growth Equity Picks - خودرو بانک
Is Network 1 Technologies Inc. forming bullish engulfing patternsPortfolio Growth Summary & Precise Buy Zone Tips - خودرو بانک
Bond Watch: Will NeoGenomics Inc stock hit new highs in YEARGlobal Markets & Growth Focused Entry Point Reports - خودرو بانک
RSI Check: Is NeoGenomics Inc stock a good pick for beginnersJuly 2025 News Drivers & Technical Buy Zone Confirmation - خودرو بانک
Volume Report: Should you buy the dip on NeoGenomics IncMarket Trend Report & Fast Entry and Exit Trade Plans - خودرو بانک
Bear Alert: Is NeoGenomics Inc forming bullish engulfing patterns2025 Top Decliners & Fast Moving Trade Plans - خودرو بانک
Exact Sciences’ Cancerguard™ Launch Could Be a Game Changer for NeoGenomics (NEO) - Sahm
Risk Off: Does BWMX meet Warren Buffett’s criteriaPortfolio Return Summary & Reliable Entry Point Alerts - خودرو بانک
Insider Buy: What is the Moat Score of Banzai International Inc2025 Volume Leaders & Weekly Momentum Stock Picks - خودرو بانک
Fred Alger Management LLC Reduces Holdings in NeoGenomics, Inc. $NEO - MarketBeat
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc.NEO - FinancialContent
Intraday pattern recognizer results for NeoGenomics Inc.July 2025 Spike Watch & Growth Focused Stock Reports - Newser
Technical signs of recovery in NeoGenomics Inc.Earnings Growth Summary & Reliable Price Breakout Signals - Newser
Neogenomics stock price target raised to $12 by TD Cowen on new product outlook - Investing.com Canada
Applying sector rotation models to NeoGenomics Inc.Trade Entry Summary & Community Verified Watchlist Alerts - Newser
Has NeoGenomics Inc. found a price floorWeekly Profit Analysis & Weekly Chart Analysis and Trade Guides - Newser
Why NeoGenomics (NEO) Shares Are Falling Today - TradingView
Finanzdaten der Neogenomics Inc-Aktie (NEO)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.01%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):